Renovacare Inc (RCAR) 1.4000 $RCAR CORRECTING a
Post# of 273254
Posted On: 09/25/2016 3:13:15 PM
Renovacare Inc (RCAR) 1.4000 $RCAR
CORRECTING and REPLACING VIDEO Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
BusinessWire - Tue May 31, 10:29AM CDT
Please replace the video with the accompanying corrected video.
Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
BusinessWire - Tue May 31, 8:57AM CDT
RenovaCare, Inc., (OTCQB:RCAR) today announced positive spray test results demonstrating that its novel SkinGun(TM) technology achieves exceptionally-uniform distribution of fluids with 200 times greater coverage than conventional methods. These outcomes are especially promising to scientists developing patented RenovaCare CellMist(TM) and SkinGun(TM) technologies* for spraying fluids containing a patient's own stem cells onto burns and wounds for rapid scar-free healing.
New Study: RenovaCare SkinGun(TM) Ultra-Gently Sprays Human Stem Cells to Achieve 'Gold-Standard' Viability for Skin Regeneration
BusinessWire - Tue May 03, 8:15AM CDT
RenovaCare, Inc., (OTCQB:RCAR), a developer of novel medical grade liquid spray devices and patented CellMist(TM) and SkinGun(TM) technologies*, today announced favorable outcomes from laboratory studies conducted by Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charite - Universitatsmedizin Berlin, one of the world's largest university hospitals.
RenovaCare, Inc. Names Renowned Skin Surgeon Steven Q. Wang, MD to Board of Advisors
BusinessWire - Tue Feb 09, 8:15AM CST
RenovaCare, Inc., developer of patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Steven Q. Wang to its Board of Advisors. Dr. Wang is Head of Dermatology Section and Director of Dermatologic Surgery and Dermatology at Memorial Sloan-Kettering Cancer Center in Basking Ridge, New Jersey.
Respected Plastic and Reconstructive Surgeon, Richard Simman, MD, Joins RenovaCare, Inc.
BusinessWire - Tue Jan 12, 8:15AM CST
RenovaCare, Inc., developer of the patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of board certified plastic and reconstructive surgeon, Richard Simman, MD, FACS, and FACCWS, to its Board of Advisors.
RenovaCare, Inc. Enters R&D Partnership with World Leading Charite
BusinessWire - Tue Nov 17, 8:15AM CST
RenovaCare, Inc. (OTCQB:RCAR), today announced a partnership to validate the science behind its groundbreaking technology for treatments of wounds, burns and other skin defects. The company's research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charite - Universitatsmedizin Berlin, one of the world's largest university hospitals.
RenovaCare elects Michael M. Barch to board of advisors
M2 - Fri Oct 16, 3:06AM CDT
Stem cell therapies company RenovaCare (OTC BB:RCAR) reported on Thursday the addition of Michael M. Barch to its board of advisors.
Accomplished Healthcare Executive, Michael M. Barch, Joins RenovaCare, Inc.
BusinessWire - Thu Oct 15, 8:15AM CDT
RenovaCare, Inc., (OTCQB:RCAR), developer of the patented CellMist(TM) and SkinGun(TM) technologies for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of healthcare executive and industry thought-leader, Michael M. Barch, to its Board of Advisors.
CORRECTING and REPLACING VIDEO Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
BusinessWire - Tue May 31, 10:29AM CDT
Please replace the video with the accompanying corrected video.
Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
BusinessWire - Tue May 31, 8:57AM CDT
RenovaCare, Inc., (OTCQB:RCAR) today announced positive spray test results demonstrating that its novel SkinGun(TM) technology achieves exceptionally-uniform distribution of fluids with 200 times greater coverage than conventional methods. These outcomes are especially promising to scientists developing patented RenovaCare CellMist(TM) and SkinGun(TM) technologies* for spraying fluids containing a patient's own stem cells onto burns and wounds for rapid scar-free healing.
New Study: RenovaCare SkinGun(TM) Ultra-Gently Sprays Human Stem Cells to Achieve 'Gold-Standard' Viability for Skin Regeneration
BusinessWire - Tue May 03, 8:15AM CDT
RenovaCare, Inc., (OTCQB:RCAR), a developer of novel medical grade liquid spray devices and patented CellMist(TM) and SkinGun(TM) technologies*, today announced favorable outcomes from laboratory studies conducted by Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charite - Universitatsmedizin Berlin, one of the world's largest university hospitals.
RenovaCare, Inc. Names Renowned Skin Surgeon Steven Q. Wang, MD to Board of Advisors
BusinessWire - Tue Feb 09, 8:15AM CST
RenovaCare, Inc., developer of patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Steven Q. Wang to its Board of Advisors. Dr. Wang is Head of Dermatology Section and Director of Dermatologic Surgery and Dermatology at Memorial Sloan-Kettering Cancer Center in Basking Ridge, New Jersey.
Respected Plastic and Reconstructive Surgeon, Richard Simman, MD, Joins RenovaCare, Inc.
BusinessWire - Tue Jan 12, 8:15AM CST
RenovaCare, Inc., developer of the patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of board certified plastic and reconstructive surgeon, Richard Simman, MD, FACS, and FACCWS, to its Board of Advisors.
RenovaCare, Inc. Enters R&D Partnership with World Leading Charite
BusinessWire - Tue Nov 17, 8:15AM CST
RenovaCare, Inc. (OTCQB:RCAR), today announced a partnership to validate the science behind its groundbreaking technology for treatments of wounds, burns and other skin defects. The company's research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charite - Universitatsmedizin Berlin, one of the world's largest university hospitals.
RenovaCare elects Michael M. Barch to board of advisors
M2 - Fri Oct 16, 3:06AM CDT
Stem cell therapies company RenovaCare (OTC BB:RCAR) reported on Thursday the addition of Michael M. Barch to its board of advisors.
Accomplished Healthcare Executive, Michael M. Barch, Joins RenovaCare, Inc.
BusinessWire - Thu Oct 15, 8:15AM CDT
RenovaCare, Inc., (OTCQB:RCAR), developer of the patented CellMist(TM) and SkinGun(TM) technologies for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of healthcare executive and industry thought-leader, Michael M. Barch, to its Board of Advisors.
(0)
(0)Scroll down for more posts ▼